Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
94 participants
INTERVENTIONAL
2017-11-08
2018-11-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Platycodon Grandiflorus Extract(GCWB107) on Decrease of Body Fat
NCT04023864
Efficacy and Safety of Unripe Bokbunja Extract on Improvement of Blood Cholesterol
NCT03649620
Efficacy and Safety of Angelica Gigas N. Extract on Improvement of Blood Triglyceride
NCT03079648
The Effect of Coleus Forskohlii Extract on the Risk Factors of Metabolic Syndrome
NCT02143349
Nigella Sativa Supplementation in Hyperlipidemia Treatment
NCT06890546
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test group
taken 3 tablets of Gelidium elegans extract (1000 mg/day) once a day for 12 weeks
Exract of Gelidium elegans
Exract of Gelidium elegans will be given to the test group.
Control group
taken 3 tablets of placebo once a day for 12 weeks
Placebo
Placebo supplement will be given to the test group.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exract of Gelidium elegans
Exract of Gelidium elegans will be given to the test group.
Placebo
Placebo supplement will be given to the test group.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2\. BMI is at or greater than 23 and less than 30 kg/m\^2
Exclusion Criteria
* 2\. uncontrolled diabetes
* 3\. current serious cerebrovascular and cardiovascular disease
19 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yonsei University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Family Medicine, Severance Hospital, College of Medicine, Yonsei University
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4-2017-0860
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.